新辅助治疗——对直肠癌现有治疗模式的挑战?。
Neoadjuvant radiochemotherapy: A challenge for the treatment of rectal cancer?
EUS对新辅助治疗后的直肠癌进行再分期的准确率降低。
The accuracy of EUS restaging rectal cancer after neoadjuvant therapy is decreased.
超过90%的复发在新辅助治疗后2年内发现，而单纯食管癌切除术后3年发现。
More than 90% of recurrences were detected within 2 years after neoadjuvant therapy, compared with 3 years after esophagectomy alone.
目前已证实，几种化疗药可作为某些转移性癌症患者的新辅助治疗或辅助治疗药。
Several chemotherapeutic agents have proven to be useful as neoadjuvant or adjuvant treatment and in patients with metastatic disease.
另一方面，使用化学治疗或放射治疗的辅助治疗和新辅助治疗因有大量的短期或长期副作用会影响生活质量。
On the other hand, adjuvant and neoadjuvant therapy with chemotherapy and radiotherapy impacts on quality of life due to substantial short - and long-term side effects.
目的：探讨动态增强序列对原发直肠癌患者术前分期的评估价值及直肠癌血液微循环在新辅助治疗前后变化。
Purpose:To determine whether addition of gadolinium-enhanced LAVA sequence to MR routine scan imaging is valuable for preoperative assessment of TN stage in patients with primary rectal cancer.
目的：评估在局部进展期直肠癌患者中联合贝伐单抗和标准放化疗的新辅助治疗有效性和安全性，并探索标志物反应。
Purpose To assess the safety and efficacy of neoadjuvant bevacizumab with standard chemoradiotherapy in locally advanced rectal cancer and explore biomarkers for response.
结果：36例患者中29例(80%)经新辅助治疗后病情缓解，可以手术。其中27例由化疗获得，2例由内分泌治疗获得。
Results: After neoadjuvant therapy, 29 (80%) patients got partial response and some of the primary inoperable lesions became respectable, 27cases by chemotherapy, 2cases by endocrine therapy.
新的指南中包括了教育干预、药物治疗和家庭辅助工具。
The new guidelines include educational interventions, medical care and family support tools.
前言： 目的：探讨新辅助化疗在局部晚期乳腺癌治疗中的应用。
Objective: To evaluate the effect of neoadjuvant chemotherapy in the treatment of locally advanced breast cancer.
目的探讨新辅助化疗在晚期乳腺癌治疗中的效果。
Objective To study the clinical effect of neoadjuvant chemotherapy on advanced breast cancer.
最近，新辅助放化疗的出现已经根本改变了限局型浸润型结肠癌患者的治疗方式。
More recently, the emergence of neo-adjuvant chemoradiotherapy has fundamentally changed the management of patients with locally advanced disease.
该研究对接受综合模式治疗的LRRC患者进行了评估，该模式包括新辅助放化疗、扩大切除术和术中放疗。
This study assessed the outcome of LRRC patients treated with multimodality treatment, consisting of neoadjuvant radio (chemo-) therapy, extended resection, and intraoperative radiotherapy.
结论混沌动力学在心率变异信号处理中的应用有望为某些心脏疾病的辅助临床诊断和治疗提供一个新的途径。
Conclusion The application of Chaos dynamics in heart rate variability signal processing may pave a new way for aided clinical diagnoses and treatment of some cardiopathies.
方法：对11例四肢骨肉瘤患者进行保肢治疗，其中11例进行了术前、后新辅助化疗。
Method: 11 patients with the diagnosis of osteosarcomas of the extremities were treated with adjuvant chemotherapy and limb salvage surgery.
目的：研究表柔比星加紫杉醇新辅助化疗方案治疗乳腺癌的近期疗效及毒副反应。
Purpose: To study the short-term efficacy and toxicity of the neoajuvant chemotherapy with epirubicin (EPI) plus paclitaxel( TAX) in treatment of patients with breast cancer.
目的评价保肢手术结合新辅助化疗治疗肢体骨肉瘤的临床疗效。
Objecttive To evaluate the clinical effectiveness of limb salvage surgery combined with new adjuvant chemotherapy for extremity osteosarcoma.
该文主要对近年来新辅助化疗在胃癌治疗中的现状进行了综述。
The present status of neoadjuvant chemotherapy for the treatment of gastric cancer was reviewed in this article.
目的研究新辅助化疗在中晚期乳腺癌保乳治疗中的应用价值。
Objective To study the value of pre-operative chemotherapy combined with breast conservation surgery for the treatment of middle-advanced breast cancer.
VEGF靶向治疗有可能成为肾细胞癌新的辅助治疗标准。
Therapy targeting of VEGF signaling may becomes the new adjuvant treatment standard in RCC.
目的评价CEF方案新辅助化疗治疗局部晚期乳腺癌的临床疗效和毒性反应。
Objective to evaluate the clinical efficacy and toxicity of CEF as the neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer (LABC).
选择性COX - 2抑制剂可联合化疗、内分泌治疗及生物治疗等，作为肿瘤治疗的辅助药物应用于临床，为乳腺癌的治疗提供一种新的途径。
Selective COX-2 inhibitors can combine with chemotherapy, endocrine therapy and biotherapy. It is gradually used for adjunctive therapy and provides a new pathway for the therapy of breast cancer.
目的：探讨新辅助化疗在老年乳腺癌患者治疗中的意义。
Objective: To evaluate the significance of neoadjuvant chemotherapy in elder breast cancer patients.
新的辅助治疗被广泛用于降低肝细胞肿瘤以及延缓肿瘤恶化，以减少在等待移植时死亡的病患人数。
Neoadjuvant therapies are widely used to downstage hepatocellular tumors and slow the progression of tumors so that fewer patients die while waiting for transplants.
近年来，随着肿瘤化疗研究的不断进展，宫颈癌的化学治疗尤其是新辅助化疗的应用日益受到人们的重视。
With development in research on chemotherapy of carcinomas in recent years, chemotherapy especially neoadjuvant chemotherapy of cervical cancer has attracted more and more attention.
结果扩大根治切除、新辅助放疗化疗、原位肝移植、光动力学治疗和分子放化疗均能有效地提高患者的生存率。
Results Extended radical resection, neoadjuvant chemotherapy, orthotopic liver transplantation, photodynamic therapy and molecular chemoradiotherapy might improve the survival rate.
术前辅以新辅助化疗，术后辅以正规内分泌治疗是提高局部晚期乳腺癌生存率的必要手段。
The neoadjuvant chemotherapy and regular endocrine therapy are the necessary measures to improve the survival rates of locally advanced breast cancer.
新辅助化疗结合间隔手术作为晚期卵巢癌患者的替代治疗方案具有较好的应用前景。
As a promising alternative to standard primary surgery, neoadjuvant chemotherapy followed by interval surgical debulking is likely to be applicable in practice.
新辅助化疗结合间隔手术作为晚期卵巢癌患者的替代治疗方案具有较好的应用前景。
As a promising alternative to standard primary surgery, neoadjuvant chemotherapy followed by interval surgical debulking is likely to be applicable in practice.
应用推荐